Inotuzumab Ozogamicin - PF-05208773
NCT03127605
·
clinicaltrials.gov ↗
APPROVED_FOR_MARKETING
Status
INDUSTRY
Sponsor class
Interventions
DRUG:
Inotuzumab Ozogamicin
Sponsor
Pfizer